Velișcu, E.M.; Liguori, V.; Anatriello, A.; Maniscalco, G.T.; Cantone, A.; Di Costanzo, L.; Stefanelli, P.; Scavone, C.; Capuano, A.
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System. Pharmaceuticals 2023, 16, 1071.
https://doi.org/10.3390/ph16081071
AMA Style
Velișcu EM, Liguori V, Anatriello A, Maniscalco GT, Cantone A, Di Costanzo L, Stefanelli P, Scavone C, Capuano A.
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System. Pharmaceuticals. 2023; 16(8):1071.
https://doi.org/10.3390/ph16081071
Chicago/Turabian Style
Velișcu, Elena Mirabela, Valerio Liguori, Antonietta Anatriello, Giorgia Teresa Maniscalco, Andrea Cantone, Luigi Di Costanzo, Pasquale Stefanelli, Cristina Scavone, and Annalisa Capuano.
2023. "Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System" Pharmaceuticals 16, no. 8: 1071.
https://doi.org/10.3390/ph16081071
APA Style
Velișcu, E. M., Liguori, V., Anatriello, A., Maniscalco, G. T., Cantone, A., Di Costanzo, L., Stefanelli, P., Scavone, C., & Capuano, A.
(2023). Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System. Pharmaceuticals, 16(8), 1071.
https://doi.org/10.3390/ph16081071
